Global Cell-Free DNA (cfDNA) Testing Market Analysis 2016 - Forecast to 2022

  • ID: 3845853
  • Report
  • Region: Global
  • 125 pages
  • Hoovers Research
1 of 3
This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Cell-Free DNA (cfDNA) Testing". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:
- Market Sizing estimations and forecasts for a minimum of 6 years of all the given segments, sub segments and the regional markets
- Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Regional and country level market analysis
- Competitive landscaping mapping the key common trends
- Company profiling covering the financials, recent activities and the future strategies
- Supply chain trends mapping the recent advancements
- Strategic recommendations for the new entrants
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Cell-Free DNA (cfDNA) Testing Market by Application
5.1 Introduction
5.2 Transplantation
5.3 Gynecology
5.4 Oncology

6 Cell-Free DNA (cfDNA) Testing Market by Test Type
6.1 Introduction
6.2 Cell-Free Tumour Dna
6.2.1 Circulating Tumor Dna Tests
6.2.1.1 Ontarget Enrichment
6.2.1.2 Egfr Mutation Test V2
6.2.1.3 Pcm Kras Mutation Detection Test
6.2.1.4 Guardant360
6.2.1.5 Cancerintercept
6.2.1.6 Neolab Liquid Biopsy
6.2.1.7 Circulogene’S Finger Stick Monitoring Technology
6.2.1.8 Epi Procolon Test
6.2.1.9 Pcm Egfr Mutation Detection Test
6.2.1.10 Cologuard Test
6.2.1.11 Lbx Hcp 50
6.2.1.12 Enchanced Tam-Seq
6.2.1.13 Metdetect
6.2.1.14 Foundationact
6.2.1.15 Pcm Braf V600F Mutation Detection Test
6.2.1.16 Iceme
6.2.1.17 Others
6.3 Cell-Free Dna Prenatal Testing
6.3.1 Cell-Free Fetal Dna Tests
6.3.1.1 Nifty Test
6.3.1.2 Informed Pregnancy Screening
6.3.1.3 Safet21 Express Test
6.3.1.4 Bambni Test
6.3.1.5 Iona Test
6.3.1.6 Qnatal Advanced Test
6.3.1.7 Visibilit Test
6.3.1.8 Prena Test
6.3.1.9 Harmony Test
6.3.1.10 Maternit21 Plus Test
6.3.1.11 Prenatalis
6.3.1.12 Maternit Genome
6.3.1.13 Clarigo
6.3.1.14 Verifi Test
6.3.1.15 Panorama Test
6.3.1.16 Informaseq Test
6.4 Donor Derived Cell-Free Dna Testing
6.4.1 Allosure

7 Geographical Segmentation
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 RoW
7.4.1 Latin America
7.4.2 Middle East
7.4.3 Africa
7.4.4 Others

8 Vendor Landscaping
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiles
9.1 Guardant Health, Inc.
9.1.1 Business Overview
9.1.2 SWOT Analysis
9.1.3 Financial Overview
9.1.4 Strategy
9.1.5 Key Activities
9.2 Caredx, Inc.
9.3 Illumina, Inc.
9.4 Laboratory Corp. Of America Holdings (Labcorp)
9.5 Natera, Inc.
9.6 Berry Genomics Co. Ltd
9.7 Inivata Limited
9.8 Trovagene, Inc.
9.9 Bgi (Bgi Diagnostics)
9.10 Biocept, Inc.
9.11 Quest Diagnostics
9.12 Roche Holdings Ag
9.13 Lifecodexx Ag
9.14 Sequenom, Inc.
9.15 Personal Genome Diagnostics

10 Appendix
11 Disclaimer

List of Tables
Table 1 Global Cell-Free DNA (cfDNA) Testing Market Analysis, by Region, 2013-2022 ($MN)
Table 2 Global Cell-Free DNA (cfDNA) Testing Market Analysis, by Application, 2013-2022 ($MN)
Table 3 Global Transplantation Market Analysis, by Region, 2013-2022 ($MN)
Table 4 Global Transplantation Market Analysis, by Test Type, 2013-2022 ($MN)
Table 5 Global Gynecology Market Analysis, by Region, 2013-2022 ($MN)
Table 6 Global Gynecology Market Analysis, by Test Type, 2013-2022 ($MN)
Table 7 Global Oncology Market Analysis, by Region, 2013-2022 ($MN)
Table 8 Global Oncology Market Analysis, by Test Type, 2013-2022 ($MN)
Table 9 Global Cell-Free DNA (cfDNA) Testing Market Analysis, by Test Tpe, 2013-2022 ($MN)
Table 10 Global Cell-Free Tumour Dna Market Analysis, by Region, 2013-2022 ($MN)
Table 11 Global Cell-Free Tumour Dna Market Analysis, by Application, 2013-2022 ($MN)
Table 12 Global Cell-Free Dna Prenatal Testing Market Analysis, by Region, 2013-2022 ($MN)
Table 13 Global Cell-Free Dna Prenatal Testing Market Analysis, by Application, 2013-2022 ($MN)
Table 14 Global Donor Derived Cell-Free Dna Testing Market Analysis, by Region, 2013-2022 ($MN)
Table 15 Global Donor Derived Cell-Free Dna Testing Market Analysis, by Application, 2013-2022 ($MN)
Table 16 North America Cell-Free DNA (cfDNA) Testing Market Analysis, by Country, 2013-2022 ($MN)
Table 17 North America Cell-Free DNA (cfDNA) Testing Market Analysis, by Application, 2013-2022 ($MN)
Table 18 North America Transplantation Market Analysis, by Country, 2013-2022 ($MN)
Table 19 North America Transplantation Market Analysis, by Test Type, 2013-2022 ($MN)
Table 20 North America Gynecology Market Analysis, by Country, 2013-2022 ($MN)
Table 21 North America Gynecology Market Analysis, by Test Type, 2013-2022 ($MN)
Table 22 North America Oncology Market Analysis, by Country, 2013-2022 ($MN)
Table 23 North America Oncology Market Analysis, by Test Type, 2013-2022 ($MN)
Table 24 North America Cell-Free DNA (cfDNA) Testing Market Analysis, by Test Tpe, 2013-2022 ($MN)
Table 25 North America Cell-Free Tumour Dna Market Analysis, by Country, 2013-2022 ($MN)
Table 26 North America Cell-Free Tumour Dna Market Analysis, by Application, 2013-2022 ($MN)
Table 27 North America Cell-Free Dna Prenatal Testing Market Analysis, by Country, 2013-2022 ($MN)
Table 28 North America Cell-Free Dna Prenatal Testing Market Analysis, by Application, 2013-2022 ($MN)
Table 29 North America Donor Derived Cell-Free Dna Testing Market Analysis, by Country, 2013-2022 ($MN)
Table 30 North America Donor Derived Cell-Free Dna Testing Market Analysis, by Application, 2013-2022 ($MN)
Table 31 Europe Cell-Free DNA (cfDNA) Testing Market Analysis, by Country, 2013-2022 ($MN)
Table 32 Europe Cell-Free DNA (cfDNA) Testing Market Analysis, by Application, 2013-2022 ($MN)
Table 33 Europe Transplantation Market Analysis, by Country, 2013-2022 ($MN)
Table 34 Europe Transplantation Market Analysis, by Test Type, 2013-2022 ($MN)
Table 35 Europe Gynecology Market Analysis, by Country, 2013-2022 ($MN)
Table 36 Europe Gynecology Market Analysis, by Test Type, 2013-2022 ($MN)
Table 37 Europe Oncology Market Analysis, by Country, 2013-2022 ($MN)
Table 38 Europe Oncology Market Analysis, by Test Type, 2013-2022 ($MN)
Table 39 Europe Cell-Free DNA (cfDNA) Testing Market Analysis, by Test Tpe, 2013-2022 ($MN)
Table 40 Europe Cell-Free Tumour Dna Market Analysis, by Country, 2013-2022 ($MN)
Table 41 Europe Cell-Free Tumour Dna Market Analysis, by Application, 2013-2022 ($MN)
Table 42 Europe Cell-Free Dna Prenatal Testing Market Analysis, by Country, 2013-2022 ($MN)
Table 43 Europe Cell-Free Dna Prenatal Testing Market Analysis, by Application, 2013-2022 ($MN)
Table 44 Europe Donor Derived Cell-Free Dna Testing Market Analysis, by Country, 2013-2022 ($MN)
Table 45 Europe Donor Derived Cell-Free Dna Testing Market Analysis, by Application, 2013-2022 ($MN)
Table 46 Asia Pacific Cell-Free DNA (cfDNA) Testing Market Analysis, by Country, 2013-2022 ($MN)
Table 47 Asia Pacific Cell-Free DNA (cfDNA) Testing Market Analysis, by Application, 2013-2022 ($MN)
Table 48 Asia Pacific Transplantation Market Analysis, by Country, 2013-2022 ($MN)
Table 49 Asia Pacific Transplantation Market Analysis, by Test Type, 2013-2022 ($MN)
Table 50 Asia Pacific Gynecology Market Analysis, by Country, 2013-2022 ($MN)
Table 51 Asia Pacific Gynecology Market Analysis, by Test Type, 2013-2022 ($MN)
Table 52 Asia Pacific Oncology Market Analysis, by Country, 2013-2022 ($MN)
Table 53 Asia Pacific Oncology Market Analysis, by Test Type, 2013-2022 ($MN)
Table 54 Asia Pacific Cell-Free DNA (cfDNA) Testing Market Analysis, by Test Tpe, 2013-2022 ($MN)
Table 55 Asia Pacific Cell-Free Tumour Dna Market Analysis, by Country, 2013-2022 ($MN)
Table 56 Asia Pacific Cell-Free Tumour Dna Market Analysis, by Application, 2013-2022 ($MN)
Table 57 Asia Pacific Cell-Free Dna Prenatal Testing Market Analysis, by Country, 2013-2022 ($MN)
Table 58 Asia Pacific Cell-Free Dna Prenatal Testing Market Analysis, by Application, 2013-2022 ($MN)
Table 59 Asia Pacific Donor Derived Cell-Free Dna Testing Market Analysis, by Country, 2013-2022 ($MN)
Table 60 Asia Pacific Donor Derived Cell-Free Dna Testing Market Analysis, by Application, 2013-2022 ($MN)
Table 61 RoW Cell-Free DNA (cfDNA) Testing Market Analysis, by Country, 2013-2022 ($MN)
Table 62 RoW Cell-Free DNA (cfDNA) Testing Market Analysis, by Application, 2013-2022 ($MN)
Table 63 RoW Transplantation Market Analysis, by Country, 2013-2022 ($MN)
Table 64 RoW Transplantation Market Analysis, by Test Type, 2013-2022 ($MN)
Table 65 RoW Gynecology Market Analysis, by Country, 2013-2022 ($MN)
Table 66 RoW Gynecology Market Analysis, by Test Type, 2013-2022 ($MN)
Table 67 RoW Oncology Market Analysis, by Country, 2013-2022 ($MN)
Table 68 RoW Oncology Market Analysis, by Test Type, 2013-2022 ($MN)
Table 69 RoW Cell-Free DNA (cfDNA) Testing Market Analysis, by Test Tpe, 2013-2022 ($MN)
Table 70 RoW Cell-Free Tumour Dna Market Analysis, by Country, 2013-2022 ($MN)
Table 71 RoW Cell-Free Tumour Dna Market Analysis, by Application, 2013-2022 ($MN)
Table 72 RoW Cell-Free Dna Prenatal Testing Market Analysis, by Country, 2013-2022 ($MN)
Table 73 RoW Cell-Free Dna Prenatal Testing Market Analysis, by Application, 2013-2022 ($MN)
Table 74 RoW Donor Derived Cell-Free Dna Testing Market Analysis, by Country, 2013-2022 ($MN)
Table 75 RoW Donor Derived Cell-Free Dna Testing Market Analysis, by Application, 2013-2022 ($MN)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll